157 related articles for article (PubMed ID: 17460532)
1. Role of small animal PET in stimulating the development of new radiopharmaceuticals in oncology.
Nanni C; Rubello D; Khan S; Al-Nahhas A; Fanti S
Nucl Med Commun; 2007 Jun; 28(6):427-9. PubMed ID: 17460532
[No Abstract] [Full Text] [Related]
2. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.
Müller C; Schibli R
J Nucl Med; 2011 Jan; 52(1):1-4. PubMed ID: 21149477
[TBL] [Abstract][Full Text] [Related]
3. Important parameters to consider for the characterization of PET and SPECT imaging probes.
Chopra A; Shan L; Eckelman WC; Leung K; Menkens AE
Nucl Med Biol; 2011 Nov; 38(8):1079-84. PubMed ID: 21855359
[No Abstract] [Full Text] [Related]
4. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in oncology.
Berry JD; Cook GJ
Br Med Bull; 2006; 79-80():171-86. PubMed ID: 17169969
[TBL] [Abstract][Full Text] [Related]
6. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016
[TBL] [Abstract][Full Text] [Related]
7. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
Pace L; Salvatore M; Del Vecchio S
J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
[No Abstract] [Full Text] [Related]
8. [Prospect of hypoxia imaging of nuclear medicine in tumors].
Chen G; Wang RF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):335-inside back cover. PubMed ID: 16778985
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of cancer using PET and SPECT.
Kjaer A
Adv Exp Med Biol; 2006; 587():277-84. PubMed ID: 17163171
[TBL] [Abstract][Full Text] [Related]
10. Primer on imaging technologies for cancer.
Schnall M; Rosen M
J Clin Oncol; 2006 Jul; 24(20):3225-33. PubMed ID: 16829646
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging as a cancer biomarker.
Yu EY; Mankoff DA
Expert Rev Mol Diagn; 2007 Sep; 7(5):659-72. PubMed ID: 17892371
[TBL] [Abstract][Full Text] [Related]
12. PET and SPECT Imaging of the Brain: History, Technical Considerations, Applications, and Radiotracers.
Davis KM; Ryan JL; Aaron VD; Sims JB
Semin Ultrasound CT MR; 2020 Dec; 41(6):521-529. PubMed ID: 33308491
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
14. Advancing a molecular theory of disease.
Wagner HN
J Nucl Med; 2008 Aug; 49(8):15N-34N. PubMed ID: 18672466
[No Abstract] [Full Text] [Related]
15. Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies.
Gutfilen B; Valentini G
Biomed Res Int; 2014; 2014():426892. PubMed ID: 25587535
[No Abstract] [Full Text] [Related]
16. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
[TBL] [Abstract][Full Text] [Related]
17. Targeted molecular imaging in oncology.
Yang DJ; Kim EE; Inoue T
Ann Nucl Med; 2006 Jan; 20(1):1-11. PubMed ID: 16485568
[TBL] [Abstract][Full Text] [Related]
18. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
19. 18-Fluorodeoxyglucose imaging in oncology.
Harolds JA
J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
[TBL] [Abstract][Full Text] [Related]
20. Vitamin-based radiopharmaceuticals for tumor imaging.
Sahin MC; Sanli S
Med Oncol; 2023 May; 40(6):165. PubMed ID: 37129735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
